Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
Portfolio Pulse from
Teva Pharmaceutical Industries Ltd. will release its Q4 and full year 2024 financial results and 2025 financial guidance on January 29, 2025. A conference call and webcast will follow the release.
December 20, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Teva Pharmaceutical Industries Ltd. is set to release its Q4 and full year 2024 financial results and 2025 guidance on January 29, 2025. This event could impact the stock price based on the financial performance and future outlook.
The announcement of financial results and future guidance is a significant event for investors as it provides insights into the company's performance and future prospects. The stock price could be impacted depending on whether the results meet, exceed, or fall short of market expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100